-
1
Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7
Cyhoeddwyd 2021-06-01Pynciau: Cael y testun llawn
Erthygl -
2
Longitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy
Cyhoeddwyd 2021-03-01Pynciau: Cael y testun llawn
Erthygl -
3
Adapting MRI as a clinical outcome measure for a facioscapulohumeral muscular dystrophy trial of prednisone and tacrolimus: case report
Cyhoeddwyd 2021-01-01Pynciau: Cael y testun llawn
Erthygl -
4
Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update
Cyhoeddwyd 2021-03-01Pynciau: “...Facioscapulohumeral muscular dystrophy (FSHD)...”
Cael y testun llawn
Erthygl -
5
Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials
Cyhoeddwyd 2022-02-01Pynciau: “...facioscapulohumeral muscular dystrophy (FSHD)...”
Cael y testun llawn
Erthygl -
6
ANT1 overexpression models: Some similarities with facioscapulohumeral muscular dystrophy
Cyhoeddwyd 2022-10-01Pynciau: Cael y testun llawn
Erthygl -
7
Artificial Intelligence for Evaluation of Retinal Vasculopathy in Facioscapulohumeral Dystrophy Using OCT Angiography: A Case Series
Cyhoeddwyd 2023-03-01Pynciau: “...facioscapulohumeral muscular dystrophy (FSHD)...”
Cael y testun llawn
Erthygl